China-focused funds invest in US startup Cytek; Shopal secures $29.17m in Series B+

A clerk counts Chinese yuan and U.S. dollar banknotes at a branch of Bank of China in Taiyuan

Cytek Biosciences, a US-based provider of instruments for researchers and clinicians, has secured an undisclosed sum in a round co-anchored by two China-focused funds while Chinese brand promotion platform Shopal raised Rmb200 million ($29.17 million) in Series B+ round.

Continue reading this story with a subscription to DealStreetAsia.


Contact us for corporate subscriptions at